Loading
A phase 3 trial in colorectal cancer, run by Jun Huang, now recruiting.
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases is a phase 3, interventional study registered as NCT06794086 by Jun Huang, with a registry enrolment figure of 24 participants, started 2025-04-10 and due to reach its primary completion in 2026-06-20. Interventions recorded: Stereotactic body radiation therapy; PD-1 Monoclonal Antibody; Chemotherapy. Conditions listed: Colorectal Cancer; Liver Metastases. Primary outcome: ORR. Colorectal eligibility wording from the registry: "Patients with pMMR/MSS colorectal adenocarcinoma;". Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares SBRT / SABR (stereotactic radiotherapy), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/